List of Studies ( Metabolite:S-Glutathionyl-cysteine)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST000509 | AN000780 | Metabolic changes to maternal rat liver tissue during and post-pregnancy | Liver | Rat | University of Colorado, Denver | Arbitrary units | |
ST000510 | AN000782 | Assessing metabolic changes to maternal rat liver tissue during and post-pregnancy (part II) | Liver | Mouse | University of Colorado, Denver | Arbitrary units | |
ST002759 | AN004479 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney cortex) | Kidney cortex | Rat | Medical College of Wisconsin | Area | |
ST002760 | AN004484 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney outer medulla) | Kidney outer medulla | Rat | Medical College of Wisconsin | Area | |
ST002058 | AN003350 | Muscle/Lung/Tumor metabolomics | Lung | Mouse | Cancer | University of Colorado Anschutz Medical Campus | AU |
ST002058 | AN003350 | Muscle/Lung/Tumor metabolomics | Muscle | Mouse | Cancer | University of Colorado Anschutz Medical Campus | AU |
ST002059 | AN003353 | 4T1 and SkM cells | Cultured cells | Human | Cancer | University of Colorado Anschutz Medical Campus | AU |
ST002747 | AN004454 | Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections | Cultured cells | Human | CZ Biohub | counts, height | |
ST002747 | AN004454 | Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections | Cultured cells | Rickettsia parkeri | CZ Biohub | counts, height | |
ST002747 | AN004455 | Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections | Cultured cells | Human | CZ Biohub | counts, height | |
ST002747 | AN004455 | Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections | Cultured cells | Rickettsia parkeri | CZ Biohub | counts, height | |
ST001788 | AN002899 | β-Adrenergic regulation of metabolism in macrophages (part-IV) | Macrophages | Human | Monash University | Intensity | |
ST002751 | AN004464 | Biomolecular condensates create phospholipid-enriched microenvironments (Part 5) | Liver | Mouse | Cornell University | Ion abundance (peak area) | |
ST002829 | AN004619 | Nucleotide, phospholipid, and kynurenine metabolites are robustly associated with COVID-19 severity and time of plasma sample collection in a prospective cohort study | Blood | Human | COVID-19 | National Institutes of Health | log transformed data |
ST001747 | AN002843 | Lung metabolomics after ischemic acute kidney injury reveals increased oxidative stress, altered energy production, and ATP depletion | Lung | Mouse | Acute kidney injury | University of Colorado Anschutz Medical Campus | peak area |
ST001864 | AN003021 | Targeting host glycolysis as a strategy for antimalarial development | Blood | Human | Malaria | University of Colorado Anschutz Medical Campus | peak area |
ST002213 | AN003620 | Metabolic changes in Alzheimer patient-derived induced neurons versus non-demented controls | Fibroblast cells | Human | Alzheimers disease | University of Colorado Denver | peak area |
ST002485 | AN004056 | Simultaneous targeting of PD-1 and IL2Rβγ with radiation therapy to inhibit pancreatic cancer growth and metastasis - mouse serum metabolomics | Blood | Mouse | Cancer | University of Colorado Denver | peak area |
ST002486 | AN004058 | Simultaneous targeting of PD-1 and IL2Rβγ with radiation therapy to inhibit pancreatic cancer growth and metastasis - mouse blood T-cell metabolomics | T-cells | Mouse | Cancer | University of Colorado Denver | peak area |
ST002498 | AN004654 | Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort | Blood | Human | Cancer | Weill Cornell Medicine | peak area |
ST002714 | AN004399 | Loss of microglial MCT4 leads to defective synaptic pruning and anxiety-like behavior in mice | Brain | Mouse | University of Colorado Denver | peak area | |
ST000230 | AN000343 | Comprehensive analysis of transcriptome and metabolome in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma | Liver | Human | Cancer | Osaka City University | Peak area |
ST000231 | AN000345 | Comprehensive analysis of transcriptome and metabolome in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma (part II) | Liver | Human | Cancer | Osaka City University | Peak area |
ST001735 | AN002824 | The COVIDome Explorer Researcher Portal (Red Blood Cells) | Blood | Human | COVID-19 | University of Colorado Anschutz Medical Campus | Peak area |
ST001736 | AN002826 | The COVIDome Explorer Researcher Portal (blood plasma) | Blood | Human | COVID-19 | University of Colorado Anschutz Medical Campus | Peak area |
ST002857 | AN004680 | Intracerebroventricular Transplantation of Foetal Allogeneic Neural Stem Cells in Patients with Secondary Progressive Multiple Sclerosis (hNSC-SPMS): a phase I dose-escalation clinical trial - Metabolomics Analysis of Human CSF and Serum | Cerebrospinal fluid | Human | Multiple sclerosis | University of Colorado | Peak area |
ST002858 | AN004685 | Intracerebroventricular Transplantation of Foetal Allogeneic Neural Stem Cells in Patients with Secondary Progressive Multiple Sclerosis (hNSC-SPMS): a phase I dose-escalation clinical trial - Metabolomics Analysis of Human Serum | Blood | Human | Multiple sclerosis | University of Colorado Anschutz Medical Campus | Peak area |
ST002909 | AN004775 | Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis | Blood | Human | Melioidosis | University of Washington | Peak area |
ST002754 | AN004468 | Metabolomics analysis of maternal obesity model | Blood | Mouse | Fatty liver disease | University of Bonn | Peak Area |
ST002852 | AN004672 | MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer | Prostate | Mouse | Cancer | University of California, Los Angeles | Peak Area |
ST002878 | AN004715 | Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy. Dynamic Labelling experiment. | Embryonic cells | Mouse | Diabetes | University of California, Los Angeles | Peak Area |
ST002031 | AN003301 | Irradiation causes alterations of polyamine, purine and sulfur metabolism in red blood cells and multiple organs (Whole blood) | Blood | Mouse | University of Colorado Anschutz Medical Campus | peak area top | |
ST002032 | AN003303 | Irradiation causes alterations of polyamine, purine and sulfur metabolism in red blood cells and multiple organs (Blood plasma) | Blood | Mouse | University of Colorado Anschutz School of Medicine | peak area top | |
ST002035 | AN003310 | Irradiation causes alterations of polyamine, purine and sulfur metabolism in red blood cells and multiple organs (Heart) | Heart | Mouse | University of Colorado Anschutz Medical Campus | peak area top | |
ST002036 | AN003312 | Irradiation causes alterations of polyamine, purine and sulfur metabolism in red blood cells and multiple organs (Kidney) | Kidney | Mouse | University of Colorado Anschutz Medical Campus | peak area top | |
ST002037 | AN003314 | Irradiation causes alterations of polyamine, purine and sulfur metabolism in red blood cells and multiple organs (Liver) | Liver | Mouse | University of Colorado Anschutz Medical Campus | peak area top | |
ST002038 | AN003316 | Irradiation causes alterations of polyamine, purine and sulfur metabolism in red blood cells and multiple organs (Duodenum) | Duodenum | Mouse | University of Colorado Anschutz Medical Campus | peak area top | |
ST002039 | AN003318 | Irradiation causes alterations of polyamine, purine and sulfur metabolism in red blood cells and multiple organs (Brain) | Brain | Mouse | University of Colorado Anschutz Medical Campus | peak area top | |
ST002040 | AN003320 | Irradiation causes alterations of polyamine, purine and sulfur metabolism in red blood cells and multiple organs (Colon) | Colon | Mouse | University of Colorado Anschutz School of Medicine | peak area top | |
ST002041 | AN003321 | Irradiation causes alterations of polyamine, purine and sulfur metabolism in red blood cells and multiple organs (Spleen) | Spleen | Mouse | University of Colorado Anschutz Medical Campus | peak area top | |
ST002066 | AN003365 | Glutaminase inhibition impairs CD8 T cell activation in STK11/Lkb1 deficient lung cancer | Lung | Mouse | Cancer | The Walter and Eliza Hall Institute of Medical Research | peak height |
ST002792 | AN004542 | Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria | Blood | Plasmodium falciparum | Malaria | Monash University | peak height |
ST002926 | AN004798 | Multi-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expression | Blood | Plasmodium falciparum | Malaria | Monash University | peak height |
ST000403 | AN000642 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes | Cells | Human | Monash Institute of Pharmaceutical Sciences, Monash University | Peak height | |
ST000539 | AN000818 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) | Cells | Human | Monash Institute of Pharmaceutical Sciences, Monash University | Peak height | |
ST000546 | AN000832 | Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant Plasmodium | Cells | Plasmodium falciparum | Malaria | Monash Institute of Pharmaceutical Sciences, Monash University | Peak height |
ST001033 | AN001694 | Determination of mode of action of anti-malalrial drugs using untargeted metabolomics | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak height |
ST001274 | AN002115 | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | Peak height |
ST001276 | AN002117 | Development and Characterisation of a Novel Class of Aroyl Guanidine Containing Anti-Trypanosomal Compounds | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | Peak height |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides fragilis | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides thetaiotaomicron | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides uniformis | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Blautia producta | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium clostridioforme | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium hathewayi | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium hylemonae | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium scindens | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium symbiosum | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus faecalis | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus faecium | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus hirae | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Escherichia fergusonii | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Flavonifractor plautii | Stanford University | Peak height | |
ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Parabacteroides distasonis | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides fragilis | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides thetaiotaomicron | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides uniformis | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Blautia producta | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium clostridioforme | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium hathewayi | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium hylemonae | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium scindens | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium symbiosum | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus faecalis | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus faecium | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus hirae | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Escherichia fergusonii | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Flavonifractor plautii | Stanford University | Peak height | |
ST002832 | AN004626 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Parabacteroides distasonis | Stanford University | Peak height | |
ST002815 | AN004582 | Investigation of metabolism in hypertrophic cardiomyopathy - HILIC | Heart | Mouse | Cardiomyopathy | University of California, San Francisco | peak heights |
ST001201 | AN001998 | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | Peak intensity |
ST001201 | AN001998 | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak intensity |
ST001202 | AN002000 | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | Peak intensity |
ST001202 | AN002000 | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak intensity |
ST001204 | AN002004 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | Peak intensity |
ST001204 | AN002004 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak intensity |
ST001205 | AN002006 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | Peak intensity |
ST001205 | AN002006 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | Peak intensity |
ST001547 | AN002576 | β-Adrenergic regulation of metabolism in macrophages | Macrophages | Human | Monash University | Peak intensity | |
ST001549 | AN002580 | β-Adrenergic regulation of metabolism in macrophages (part-III) | Macrophages | Human | Monash University | Peak intensity | |
ST002818 | AN004586 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) | Blood | Human | Tufts Medical Center | raw area counts rescaled to set the median equal to 1 | |
ST002820 | AN004594 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) | Blood | Human | Tufts Medical Center | raw area counts rescaled to set the median equal to 1 | |
ST001730 | AN002816 | Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance | Cultured cells | Human | Cancer | University of Colorado Denver | Relative Abundance |
ST001731 | AN002818 | Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance (part-II) | Cultured cells | Human | Cancer | University of Colorado Denver | Relative Abundance |
ST002109 | AN003451 | Towards a mechanistic understanding of patient response to neoadjuvant SBRT with anti-PDL1 in human HPV-unrelated locally advanced HNSCC: Phase I/Ib trial results (Part 1) | Blood | Human | Cancer | University of Colorado Denver | Relative Abundance |
ST002110 | AN003452 | Towards a mechanistic understanding of patient response to neoadjuvant SBRT with anti-PDL1 in human HPV-unrelated locally advanced HNSCC: Phase I/Ib trial results (Part 2) | Blood | Human | Cancer | University of Colorado Denver | Relative Abundance |
ST002309 | AN003772 | Targeting malaria parasites with novel derivatives of azithromycin | Blood | Plasmodium falciparum | Malaria | Monash University | relative intensity |
ST001175 | AN001950 | Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | Signal Intensity |
ST001304 | AN002172 | Multi-omics analysis delineates the distinct functions of sub-cellular acetyl-CoA pools in Toxoplasma gondii | Fibroblast cells | Toxoplasma gondii | Parasitic infection | Monash University | Signal Intensity |
ST001315 | AN002190 | Retargeting azithromycin-like compounds as antimalarials with dual modality | Blood | Plasmodium falciparum | Malaria | Monash University | Signal Intensity |